{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:12:59Z","timestamp":1792883579592,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/M009513\/1"],"award-info":[{"award-number":["BB\/M009513\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/M009513\/1"],"award-info":[{"award-number":["BB\/M009513\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Blueberry therapeutics Ltd.","award":["BB\/M009513\/1"],"award-info":[{"award-number":["BB\/M009513\/1"]}]},{"name":"Blueberry therapeutics Ltd.","award":["BB\/M009513\/1"],"award-info":[{"award-number":["BB\/M009513\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The similarities between fungal and mammalian cells pose inherent challenges for the development of treatments for fungal infections, due to drug crossover recognition of host drug targets by antifungal agents. Thus, there are a limited number of drug classes available for treatment. Treatment is further limited by the acquisition and dissemination of antifungal resistance which contributes to the urgent need of new therapies. Polyhexamethylene biguanide (PHMB) is a cationic antimicrobial polymer with bactericidal, parasiticidal and fungicidal activities. The antifungal mechanism of action appears to involve preferential mechanical disruption of microbial cell structures, offering an alternative to conventional antifungals. However, the antifungal mechanisms have been little studied. The aim of this study was to characterise PHMB\u2019s activities on selected yeast (\n                    <jats:italic>Saccharomyces cerevisiae, Candida albicans<\/jats:italic>\n                    ) and filamentous fungal species\u00a0(\n                    <jats:italic>Fusarium oxysporum, Penicillium glabrum<\/jats:italic>\n                    ). Fungal membrane disruption, cell entry and intracellular localisation activities of PHMB were evaluated using viability probe entry and polymer localisation studies. We observed that PHMB initially permeabilises fungal cell membranes and then accumulates within the cytosol. Once in the cytosol, it disrupts the nuclear membrane, leading to DNA binding and fragmentation. The electrostatic interaction of PHMB with membranes suggests other intracellular organelles could be potential targets of its action. Overall, the results indicate multiple antifungal mechanisms, which may help to explain its broad-spectrum efficacy. A better understanding of PHMB\u2019s mechanism(s) of action may aid the development of improved antifungal treatment strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-29756-w","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T08:03:12Z","timestamp":1676534592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Fungal cell barriers and organelles are disrupted by polyhexamethylene biguanide (PHMB)"],"prefix":"10.1038","volume":"13","author":[{"given":"Winnie","family":"Ntow-Boahene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Papandronicou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephous","family":"Miculob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"2","key":"29756_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3201\/eid2302.152042","volume":"23","author":"D Denning","year":"2017","unstructured":"Denning, D. et al. Delivering on antimicrobial resistance agenda not pohttps:\/\/doi.org\/10.3201\/eid2302.152042ssible without improving fungal diagnostic capabilities. Emerg. Infect. Dis. 23(2), 177\u2013183 (2017).","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"29756_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof2040026","volume":"2","author":"KM Pianalto","year":"2016","unstructured":"Pianalto, K. M. & Alspaugh, J. A. New horizons in antifungal therapy. J. Fungi (Basel) 2(4), 26. https:\/\/doi.org\/10.3390\/jof2040026 (2016).","journal-title":"J. Fungi (Basel)"},{"key":"29756_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bcp.2016.11.019","volume":"133","author":"S Campoy","year":"2017","unstructured":"Campoy, S. & Adrio, J. L. Antifungals. Biochem. Pharmacol. 133, 86\u201396. https:\/\/doi.org\/10.1016\/j.bcp.2016.11.019 (2017).","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"29756_CR4","doi-asserted-by":"publisher","first-page":"a019703","DOI":"10.1101\/cshperspect.a019703","volume":"4","author":"T Roemer","year":"2014","unstructured":"Roemer, T. & Krysan, D. J. Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb. Perspect. Med. 4(5), a019703. https:\/\/doi.org\/10.1101\/cshperspect.a019703 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"29756_CR5","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1093\/jac\/dkw214","volume":"71","author":"MA Pfaller","year":"2016","unstructured":"Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Jones, R. N. & Castanheira, M. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates. J. Antimicrob. Chemother. 71(10), 2868\u20132873. https:\/\/doi.org\/10.1093\/jac\/dkw214 (2016).","journal-title":"J. Antimicrob. Chemother."},{"issue":"Sup12","key":"29756_CR6","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.12968\/bjon.2012.21.sup12.s16","volume":"21","author":"M Butcher","year":"2012","unstructured":"Butcher, M. PHMB: An effective antimicrobial in wound bioburden management. Br. J. Nurs.a 21(Sup12), S16\u2013S21. https:\/\/doi.org\/10.12968\/bjon.2012.21.sup12.s16 (2012).","journal-title":"Br. J. Nurs.a"},{"issue":"5","key":"29756_CR7","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/jac\/dkv474","volume":"71","author":"NF Kamaruzzaman","year":"2016","unstructured":"Kamaruzzaman, N. F., Firdessa, R. & Good, L. Bactericidal effects of polyhexamethylene biguanide against intracellular Staphylococcus aureus EMRSA-15 and USA 300. J. Antimicrob. Chemother. 71(5), 1252\u20131259. https:\/\/doi.org\/10.1093\/jac\/dkv474 (2016).","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"29756_CR8","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1515\/pac-2014-0213","volume":"86","author":"K Locock","year":"2014","unstructured":"Locock, K., Michl, T., Griesser, H., Haeussler, M. & Meagher, L. Structure\u2013activity relationships of guanylated antimicrobial polymethacrylates. Pure Appl. Chem. 86(8), 1281\u20131291.\u00a0 https:\/\/doi.org\/10.1515\/pac-2014-0213 (2014).","journal-title":"Pure Appl. Chem."},{"issue":"2","key":"29756_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbrc.2004.04.043","volume":"318","author":"MJ Allen","year":"2004","unstructured":"Allen, M. J., Morby, A. P. & White, G. F. Cooperativity in the binding of the cationic biocide polyhexamethylene biguanide to nucleic acids. Biochem. Biophys. Res. Commun. 318(2), 397\u2013404. https:\/\/doi.org\/10.1016\/j.bbrc.2004.04.043 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"29756_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/jac\/dkn125","volume":"61","author":"G Muller","year":"2008","unstructured":"Muller, G. & Kramer, A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J. Antimicrob. Chemother. 61(6), 1281\u20131287. https:\/\/doi.org\/10.1093\/jac\/dkn125\u00a0(2008).","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"29756_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1046\/j.1365-2672.2001.01385.x","volume":"91","author":"P Gilbert","year":"2001","unstructured":"Gilbert, P., Das, J., Jones, M. & Allison, D. Assessment of resistance towards biocides following the attachment of micro-organisms to, and growth on, surfaces. J. Appl. Microbiol. 91(2), 248\u2013254. https:\/\/doi.org\/10.1046\/j.1365-2672.2001.01385.x (2001).","journal-title":"J. Appl. Microbiol."},{"issue":"163","key":"29756_CR12","first-page":"15","volume":"41","author":"P Broxton","year":"1984","unstructured":"Broxton, P., Woodcock, P. & Gilbert, P. Binding of some polyhexamethylene biguanides to the cell envelope of Escherichia coli ATCC 8739. Microbios 41(163), 15\u201322 (1984).","journal-title":"Microbios"},{"issue":"1","key":"29756_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2672.1984.tb02363.x","volume":"57","author":"P Broxton","year":"1984","unstructured":"Broxton, P., Woodcock, P., Heatley, F. & Gilbert, P. Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli. J. Appl. Bacteriol. 57(1), 115\u2013124 (1984).","journal-title":"J. Appl. Bacteriol."},{"issue":"3","key":"29756_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/0005-2736(83)90152-9","volume":"735","author":"T Ikeda","year":"1983","unstructured":"Ikeda, T., Tazuke, S. & Watanabe, M. Interaction of biologically active molecules with phospholipid membranes: I. Fluorescence depolarization studies on the effect of polymeric biocide bearing biguanide groups in the main chain. Biochim. Biophys. Acta (BBA) Biomembr. 735(3), 380\u2013386. https:\/\/doi.org\/10.1016\/0005-2736(83)90152-9 (1983).","journal-title":"Biochim. Biophys. Acta (BBA) Biomembr."},{"issue":"1","key":"29756_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0005-2736(84)90009-9","volume":"769","author":"T Ikeda","year":"1984","unstructured":"Ikeda, T., Ledwith, A., Bamford, C. & Hann, R. Interaction of a polymeric biguanide biocide with phospholipid membranes. Biochim. Biophys. Acta BBA Biomembr. 769(1), 57\u201366.\u00a0https:\/\/doi.org\/10.1016\/0005-2736(84)90009-9 (1984).","journal-title":"Biochim. Biophys. Acta BBA Biomembr."},{"issue":"Pt 4","key":"29756_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1099\/mic.0.28643-0","volume":"152","author":"MJ Allen","year":"2006","unstructured":"Allen, M. J., White, G. F. & Morby, A. P. The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide. Microbiology 152(Pt 4), 989\u20131000. https:\/\/doi.org\/10.1099\/mic.0.28643-0 (2006).","journal-title":"Microbiology"},{"key":"29756_CR17","doi-asserted-by":"publisher","first-page":"23121","DOI":"10.1038\/srep23121","volume":"6","author":"K Chindera","year":"2016","unstructured":"Chindera, K. et al. The antimicrobial polymer PHMB enters cells and selectively condenses bacterial chromosomes. Sci. Rep. 6, 23121.\u00a0https:\/\/doi.org\/10.1038\/srep23121 (2016).","journal-title":"Sci. Rep."},{"issue":"1","key":"29756_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2199-12-38","volume":"12","author":"C Elsztein","year":"2011","unstructured":"Elsztein, C., de Lucena, R. & de Morais, M. The resistance of the yeast Saccharomyces cerevisiae to the biocide polyhexamethylene biguanide: Involvement of cell wall integrity pathway and emerging role for YAP1. BMC Mol. Biol. 12(1), 1\u201310. https:\/\/doi.org\/10.1186\/1471-2199-12-38 (2011).","journal-title":"BMC Mol. Biol."},{"issue":"3","key":"29756_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00284-016-1067-z","volume":"73","author":"C Elsztein","year":"2016","unstructured":"Elsztein, C., de Lima, R., de Barros Pita, W. & de Morais, M. NCW2, a gene involved in the tolerance to polyhexamethylene biguanide (PHMB), may help in the organisation of \u03b2-1,3-Glucan structure of saccharomyces cerevisiae cell wall. Curr. Microbiol. 73(3), 341\u2013345. https:\/\/doi.org\/10.1007\/s00284-016-1067-z (2016).","journal-title":"Curr. Microbiol."},{"key":"29756_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002718","author":"SD Singh-Babak","year":"2012","unstructured":"Singh-Babak, S. D. et al. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata. PLoS Pathog. 8(5). https:\/\/doi.org\/10.1371\/journal.ppat.1002718 (2012).","journal-title":"PLoS Pathog"},{"key":"29756_CR21","doi-asserted-by":"publisher","DOI":"10.21769\/BIOPROTOC.252","author":"JL Xie","year":"2012","unstructured":"Xie, J. L., Singh-Babak, S. D. & Cowen, L. E. Minimum inhibitory concentration (MIC) assay for antifungal drugs. Bio-Protoc. 2(20). https:\/\/doi.org\/10.21769\/BIOPROTOC.252 (2012).","journal-title":"Bio-Protoc."},{"issue":"1","key":"29756_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1365-2958.2002.03165.x","volume":"46","author":"T Edlind","year":"2002","unstructured":"Edlind, T., Smith, L., Henry, K., Katiyar, S. & Nickels, J. Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling. Mol. Microbiol. 46(1), 257\u2013268. https:\/\/doi.org\/10.1046\/j.1365-2958.2002.03165.x (2002).","journal-title":"Mol. Microbiol."},{"issue":"7","key":"29756_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1567-1364.2009.00577.x","volume":"9","author":"FC Odds","year":"2009","unstructured":"Odds, F. C. In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1. FEMS Yeast Res. 9(7), 1091\u20131101. https:\/\/doi.org\/10.1111\/j.1567-1364.2009.00577.x (2009).","journal-title":"FEMS Yeast Res."},{"issue":"4","key":"29756_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/jac\/dkn022","volume":"61","author":"A Alastruey-Izquierdo","year":"2008","unstructured":"Alastruey-Izquierdo, A., Cuenca-Estrella, M., Monzon, A., Mellado, E. & Rodriguez-Tudela, J. L. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J. Antimicrobial. Chemother. 61(4), 805\u2013809. https:\/\/doi.org\/10.1093\/jac\/dkn022 (2008).","journal-title":"J. Antimicrobial. Chemother."},{"issue":"8","key":"29756_CR25","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1128\/jcm.00960-16","volume":"54","author":"M Guevara-Suarez","year":"2016","unstructured":"Guevara-Suarez, M. et al. Identification and antifungal susceptibility of penicillium-like fungi from clinical samples in the United States. J. Clin. Microbiol. 54(8), 2155\u20132161. https:\/\/doi.org\/10.1128\/jcm.00960-16 (2016).","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"29756_CR26","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/s0021-9258(19)69848-0","volume":"256","author":"C Bordier","year":"1981","unstructured":"Bordier, C. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256(4), 1604\u20131607. https:\/\/doi.org\/10.1016\/s0021-9258(19)69848-0 (1981).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"29756_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/microbiolspec.FUNK-0035-2016","volume":"5","author":"NAR Gow","year":"2017","unstructured":"Gow, N. A. R., Latge, J. P. & Munro, C. A. The fungal cell wall: Structure, biosynthesis, and function. Microbiol. Spectr. 5(3), 5\u20133. https:\/\/doi.org\/10.1128\/microbiolspec.FUNK-0035-2016 (2017).","journal-title":"Microbiol. Spectr."},{"issue":"2\u20133","key":"29756_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/fgbi.1999.1153","volume":"27","author":"EA Schoffelmeer","year":"1999","unstructured":"Schoffelmeer, E. A., Klis, F. M., Sietsma, J. H. & Cornelissen, B. J. The cell wall of Fusarium oxysporum. Fungal Genet. Biol. 27(2\u20133), 275\u2013282.\u00a0https:\/\/doi.org\/10.1006\/fgbi.1999.1153\u00a0(1999).","journal-title":"Fungal Genet. Biol."},{"issue":"8","key":"29756_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.fgb.2010.04.006","volume":"47","author":"T Fontaine","year":"2010","unstructured":"Fontaine, T. et al. Cell wall \u03b11-3glucans induce the aggregation of germinating conidia of Aspergillus fumigatus. Fungal Genet. Biol. 47(8), 707\u2013712.\u00a0https:\/\/doi.org\/10.1016\/j.fgb.2010.04.006 (2010).","journal-title":"Fungal Genet. Biol."},{"issue":"19","key":"29756_CR30","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1128\/AEM.01506-12","volume":"78","author":"M Bekker","year":"2012","unstructured":"Bekker, M. et al. Production of an extracellular matrix as an isotropic growth phase of Penicillium rubens on gypsum. Appl. Environ. Microbiol. 78(19), 6930\u20136937. https:\/\/doi.org\/10.1128\/AEM.01506-12 (2012).","journal-title":"Appl. Environ. Microbiol."},{"issue":"2","key":"29756_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G van Meer","year":"2008","unstructured":"van Meer, G., Voelker, D. & Feigenson, G. Membrane lipids: Where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9(2), 112\u2013124.\u00a0https:\/\/doi.org\/10.1038\/nrm2330 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"29756_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/jof4020050","volume":"4","author":"J Pan","year":"2018","unstructured":"Pan, J., Hu, C. & Yu, J. Lipid biosynthesis as an antifungal target. J. Fungi 4(2), 50.\u00a0https:\/\/doi.org\/10.3390\/jof4020050\u00a0(2018).","journal-title":"J. Fungi"},{"issue":"1","key":"29756_CR33","doi-asserted-by":"publisher","first-page":"17029","DOI":"10.1038\/s41598-019-53517-3","volume":"9","author":"E Grela","year":"2019","unstructured":"Grela, E. et al. Modes of the antibiotic activity of amphotericin B against Candida albicans. Sci. Rep. 9(1), 17029.\u00a0https:\/\/doi.org\/10.1038\/s41598-019-53517-3 (2019).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29756-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29756-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29756-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T08:08:59Z","timestamp":1676534939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29756-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29756"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29756-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2056966\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"12 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are currently employees of Tecrea Ltd, a biotechnology company spin out from The Royal Veterinary College which enables nanodelivery using PHMB.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2790"}}